Unseen threat: how subclinical atherosclerosis increases mortality risk in patients with type 1 diabetes
Subclinical atherosclerosis is independently associated with increased overall mortality and MACE in patients with type 1 diabetes. Identifying clinical predictors can improve risk stratification and personalised therapeutic strategies to prevent MACEs in this high-risk population.
Authors
- Eduardo Esteve
- E.A Costa
- Monica Sala (ORCID: https://orcid.org/0000-0002-2618-1589)
- Lidia Sojo-Vega
- Mariona Esteve-Serra
- Josefina Biarnés (ORCID: https://orcid.org/0009-0007-3775-3339)
- Marzena Wos (ORCID: https://orcid.org/0009-0007-6524-3803)
- Rebeca Barahona San Millán (ORCID: https://orcid.org/0000-0002-3049-8407)
- María Buxó (ORCID: https://orcid.org/0000-0001-7165-7737)
- Mercè Fernández-Balsells (ORCID: https://orcid.org/0000-0001-8221-4237)
- Gemma Xifra
- Joan Martínez (ORCID: https://orcid.org/0000-0001-7962-709X)
- Paula Pellicer
- Carles Blay (ORCID: https://orcid.org/0000-0003-3962-5887)
- David Pérez
- Lídia Riera
- S. Mauri (ORCID: https://orcid.org/0000-0001-5275-4523)
- Maria Ayala
- A Aguilera
- Gemma Gifre
- Natàlia Admetlla
- Berta Fabregat
Institutions
- Universitat de Girona (ES)
- Catalan Institute for Water Research (ES)
- Institut d'Investigació Biomèdica de Girona (ES)
- Hospital Universitari de Girona Doctor Josep Trueta (ES)
Publication Details
- Journal
- Cardiovascular Diabetology
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1186/s12933-024-02455-0
- Citations
- 4
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 1.43